Reliq Health Technologies Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Chris Shields

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	5.4yrs

Son yönetim güncellemeleri

Recent updates

Reliq Health Technologies Inc. (CVE:RHT) Doing What It Can To Lift Shares

Jul 22

We Take A Look At Why Reliq Health Technologies Inc.'s (CVE:RHT) CEO Has Earned Their Pay Packet

Dec 15

How Much Is Reliq Health Technologies Inc. (CVE:RHT) Paying Its CEO?

Jan 28

CEO

Chris Shields

less than a year

Görev süresi

Mr. Chris Shields serves as Chief Executive Officer of Reliq Health Technologies Inc. since 2024 and served as its Interim Chief Executive Officer since December 2023 and serves as its Director since Decem...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chris Shields	CEO & Director	less than a year	Veri yok	Veri yok
Kevin Cornish	Chief Financial Officer	less than a year	Veri yok	Veri yok
Lucas Smithen	Chief Product & Technology Officer	less than a year	Veri yok	Veri yok
Joyce Johnson	Chief Medical Officer & Medical Advisory Board Member	4.3yrs	Veri yok	Veri yok
Chris Ryan	Chief Strategy & Innovation Officer	3.5yrs	Veri yok	Veri yok

0.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim: RHT 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chris Shields	CEO & Director	less than a year	Veri yok	Veri yok
Joyce Johnson	Chief Medical Officer & Medical Advisory Board Member	no data	Veri yok	Veri yok
Eugene Beukman	Director	9yrs	CA$78.00k	0.10% CA$ 48.4k
Brian Storseth	Independent Director	8yrs	CA$120.00k	0.064% CA$ 30.1k
Scott Howell	Medical Advisory Board Member	5.4yrs	Veri yok	Veri yok
Bruce Kinosian	Medical Advisory Board Member	5.4yrs	Veri yok	Veri yok
Alexander Nuttall	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Camellus Ezeugwu	Medical Advisory Board Member	no data	Veri yok	Veri yok
Leo Godreault	Medical Advisory Board Member	no data	Veri yok	Veri yok

5.4yrs

Ortalama Görev Süresi

51.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RHT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.4 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/07/30 07:33
Gün Sonu Hisse Fiyatı	2024/07/26 00:00
Kazançlar	2023/03/31
Yıllık Kazançlar	2022/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Reliq Health Technologies Inc. 3 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Gabriel Leung	Beacon Securities Limited
Allen Klee	Maxim Group
David Kwan	Ventum Financial Corp

Reliq Health Technologies Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Reliq Health Technologies Inc. Announces Resignation of Directors

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces the Appointment of Directors

Reliq Health Technologies Inc Announces Executive Changes

Reliq Health Technologies Inc. Announces the Resignation of Lisa Crossley as Director

Recent updates

Reliq Health Technologies Inc. Announces Resignation of Directors

TSX-V to Transfer Listing to Reliq Health Technologies From Tier 2 to NEX

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

New minor risk - Financial data availability

Reliq Health Technologies, Inc. Announces the Appointment of Directors

Reliq Health Technologies Inc Announces Executive Changes

Reliq Health Technologies Inc. Announces the Resignation of Lisa Crossley as Director

New minor risk - Share price stability

Reliq Health Technologies Inc., Annual General Meeting, Dec 21, 2023

Reliq Health Technologies Inc. announced that it has received CAD 6 million in funding

New minor risk - Financial position

Reliq Health Technologies Inc. announced that it expects to receive CAD 4 million in funding

Reliq Health Technologies Inc. (CVE:RHT) Doing What It Can To Lift Shares

Third quarter 2023 earnings released: EPS: CA$0.038 (vs CA$0.004 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.012 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.024 loss in 1Q 2022)

Reliq Health Technologies Inc. to Report Q2, 2023 Results on Mar 01, 2023

Less than half of directors are independent

Full year 2022 earnings released: CA$0.046 loss per share (vs CA$0.075 loss in FY 2021)

Reliq Health Technologies Inc. to Report Q1, 2023 Results on Nov 29, 2022

Reliq Health Technologies Inc., Annual General Meeting, Dec 21, 2022

CEO & Director recently bought CA$52k worth of stock

Reliq Health Technologies, Inc. Announces Court Approval of Settlement of Proposed Class Action

Third quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.017 loss in 3Q 2021)

Reliq Health Technologies Inc. to Report Fiscal Year 2022 Results on Oct 28, 2022

Less than half of directors are independent

CEO & Director exercised options to buy CA$178k worth of stock.

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Reliq Health Technologies Inc. to Report Q3, 2022 Results on May 30, 2022

Reliq Health Technologies Inc. Announces Settlement of Class Action

We Take A Look At Why Reliq Health Technologies Inc.'s (CVE:RHT) CEO Has Earned Their Pay Packet

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: CA$0.075 loss per share (vs CA$0.082 loss in FY 2020)

Reliq Health Technologies Inc. Provides Update on Significant Expansion of Texas Medicaid Coverage, More Than Doubling the Eligible Patient Population for Reliq in TX

Reliq Health Technologies Inc. Provides Sales Guidance for the Fourth Quarter and Full Year Ending June 30, 2021

Third quarter 2021 earnings released: CA$0.017 loss per share (vs CA$0.021 loss in 3Q 2020)

Reliq Health Technologies, Inc. Announces Implementation of FHIR Standard for Interoperability to Address New CMS Regulations

Reliq Health Technologies, Inc. Announces New Contract with a Physician Practice in Florida to Provide iUGO Care to over 25 Skilled Nursing Facilities

Insider recently sold CA$130k worth of stock

Second quarter 2021 earnings released: CA$0.029 loss per share (vs CA$0.03 loss in 2Q 2020)

Reliq Health Technologies Inc. Announces New Contract with US Nephrology Clinic to Provide iUGO Care to Chronic Kidney Disease Patients

Reliq Health Technologies, Inc. Announces New Contract with Care Management Network in California

New 90-day high: CA$0.55

Reliq Health Technologies, Inc. Announces First Contract to Deploy its iUGO Home Solution

How Much Is Reliq Health Technologies Inc. (CVE:RHT) Paying Its CEO?

Reliq Health Technologies Inc. Launches Its New Multilingual Interactive Voice Recognition Product, iUGO Care IVR

Reliq Health Technologies, Inc. Launches New Annual Wellness Visit Product and Announces New US Contract

Reliq Health Technologies, Inc. Announces 15 New Clients

New 90-day high: CA$0.34

Reliq Health Technologies Inc. to Report Q2, 2021 Results on Mar 02, 2021

First quarter 2021 earnings released: CA$0.018 loss per share

Reliq Health Technologies Inc. to Report Q1, 2021 Results on Nov 30, 2020

Full year earnings released - CA$0.082 loss per share

Reliq Health Technologies, Inc. Announces Strategic Alliance with iDocsWeb to Offer its iUGO Care platform to iDocsWeb's 200 Skilled Nursing Facility Clients across the United States

New 90-day high: CA$0.29

Reliq Health Technologies Inc. Signs A Contract with the University of Notre Dame Australia to Deploy iUGO Well to its Students and Staff

New 90-day low: CA$0.21

CEO & Director recently bought CA$54k worth of stock

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş

Şirket Analizi ve Finansal Veri Durumu

Veri Kaynakları

Analiz Modeli ve Kar Tanesi